Cargando…
AdipoRon Affects Cell Cycle Progression and Inhibits Proliferation in Human Osteosarcoma Cells
AdipoRon (AdipoR) is the first synthetic molecule acting as a selective and potent adiponectin receptor agonist. Recently, the possible pharmacological use of AdipoR in different pathological conditions has been addressed. Interestingly, initial evidence suggests that AdipoR may have anticancer prop...
Autores principales: | Sapio, Luigi, Nigro, Ersilia, Ragone, Angela, Salzillo, Alessia, Illiano, Michela, Spina, Annamaria, Polito, Rita, Daniele, Aurora, Naviglio, Silvio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7204133/ https://www.ncbi.nlm.nih.gov/pubmed/32411241 http://dx.doi.org/10.1155/2020/7262479 |
Ejemplares similares
-
AdipoRon and Other Adiponectin Receptor Agonists as Potential Candidates in Cancer Treatments
por: Nigro, Ersilia, et al.
Publicado: (2021) -
Integrating Gemcitabine-Based Therapy With AdipoRon Enhances Growth Inhibition in Human PDAC Cell Lines
por: Ragone, Angela, et al.
Publicado: (2022) -
AdipoRon and Pancreatic Ductal Adenocarcinoma: a future perspective in overcoming chemotherapy-induced resistance?
por: Sapio, Luigi, et al.
Publicado: (2022) -
Chlorogenic Acid Enhances Doxorubicin-Mediated Cytotoxic Effect in Osteosarcoma Cells
por: Salzillo, Alessia, et al.
Publicado: (2021) -
Targeting CREB in Cancer Therapy: A Key Candidate or One of Many? An Update
por: Sapio, Luigi, et al.
Publicado: (2020)